Project Grant R01MH136503
Award Date
12/1/24
Completion Date
10/31/29
Dollars Obligated
$1.5M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,217,886 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Feinstein Institutes for Medical Research. The goal of this 5-year project, starting on September 5, 2024, is to develop a clozapine decision support tool for first episode psychosis (FEP) patients. The tool will leverage three biomarkers - a functional brain scan, and genetic tests for weight gain and agranulocytosis risk - to predict which FEP...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $961,668 to The Feinstein Institutes for Medical Research to leverage electronic health records, dimensional phenotyping, and genetic analyses to build predictive models and identify subtypes of clinical outcomes for individuals with schizophrenia and other psychosis-related disorders. The 5-year project aims to advance precision psychiatry by...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $836,344 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on the relationship between dysfunctional neurovascular interactions and neuroprogression in early-course psychosis. The key objectives are to identify cellular-molecular substrates underlying neuroprogression in...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to identify biomarkers in the cerebellar-cortical circuitry that can predict treatment response to antipsychotic medication in patients with early psychosis. The $519,558 award, which runs from June 2025 to April 2030, will enable the Feinstein Institutes for Medical Research to validate the identified predictive biomarker in a larger sample...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants provides $2,694,945 in funding to the Lieber Institute for Brain Development to conduct research on understanding the cellular and circuit function of human-induced pluripotent stem cell (hiPSC) models in relation to the complex and heterogeneous genetic risk factors and clinical/cognitive phenotypes of schizophrenia. The research aims to: 1) replicate and expand on...
The National Institute of Mental Health (NIMH) awarded a $314,113 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Physical Sciences Inc. (PSI) of Andover, MA. The grant will fund the development and demonstration of a high-speed, multicolor confocal fluorescence imager to simultaneously capture multi-wavelength signals and display them as separated or merged multicolor images and 3-D stacks. This technology innovation will enable mapping of complex neuronal network...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is funding a $423,500 research project conducted by the University of Rochester. The project aims to derive electroencephalogram (EEG) responses from the early stages of the human visual cortex to study predictive processing in schizophrenia. Specifically, the researchers will use innovative visual stimuli and experiments to measure "perceptual...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $254,250 to New York University School of Medicine to conduct in vivo assessment of mitochondrial complex I function in individuals with schizophrenia. The project aims to utilize positron emission tomography (PET) and phosphorus magnetic resonance spectroscopy (31P-MRS) to examine brain energetics and mitochondrial function in relation to...
The National Institute of Mental Health (NIMH) awarded a $845,163 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Feinstein Institutes for Medical Research. The project aims to develop a low-cost, low-burden approach that produces accurate, objective markers of psychosis severity using automated speech and language analysis. This would serve as "vital signs" for monitoring psychosis in a longitudinal clinical context. The project will first build a...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is focused on studying the use of theta burst stimulation (TBS) to modulate hippocampal-cortical rhythms in patients with schizophrenia. The $160,272 award, effective June 1, 2025 through May 31, 2027, will support a combination of invasive and non-invasive brain stimulation experiments to investigate how TBS can influence hippocampal oscillations and...